POET Technologies (POET) had the highest return between January 20, 2018 and March 11, 2018 by a small-cap US stock, returning 200%.
| ASSET | DATE | % RETURN |
|---|---|---|
POET Technologies (POET) | 1/20/2018 - 3/11/2018 | 200% |
Nutex Health (NUTX) | 1/20/2018 - 3/11/2018 | 78.57% |
Vericel Corp Ord (VCEL) | 1/20/2018 - 3/11/2018 | 71.11% |
American Public Education (APEI) | 1/20/2018 - 3/11/2018 | 63.69% |
Iovance Biotherapeutics (IOVA) | 1/20/2018 - 3/11/2018 | 63.25% |
QuinStreet (QNST) | 1/20/2018 - 3/11/2018 | 56.37% |
Xencor (XNCR) | 1/20/2018 - 3/11/2018 | 50.09% |
Nektar Therapeutics (NKTR) | 1/20/2018 - 3/11/2018 | 49.62% |
Know Labs (KNW) | 1/20/2018 - 3/11/2018 | 49.56% |
Gyre Therapeutics (GYRE) | 1/20/2018 - 3/11/2018 | 44.41% |
Geron (GERN) | 1/20/2018 - 3/11/2018 | 43.59% |
DiaMedica Therapeutics (DMAC) | 1/20/2018 - 3/11/2018 | 43.38% |
Dine Brands Global (DIN) | 1/20/2018 - 3/11/2018 | 43.33% |
Editas Medicine (EDIT) | 1/20/2018 - 3/11/2018 | 42.75% |
Liquidity Services (LQDT) | 1/20/2018 - 3/11/2018 | 42% |
Rocket Pharmaceuticals (RCKT) | 1/20/2018 - 3/11/2018 | 38.31% |
Onity (ONIT) | 1/20/2018 - 3/11/2018 | 37.1% |
Herbalife Nutrition (HLF) | 1/20/2018 - 3/11/2018 | 37% |
Transcontinental Realty Investors (TCI) | 1/20/2018 - 3/11/2018 | 36.4% |
Vanda Pharmaceuticals (VNDA) | 1/20/2018 - 3/11/2018 | 35.84% |
Paysign (PAYS) | 1/20/2018 - 3/11/2018 | 35.12% |
Clearpoint Neuro (CLPT) | 1/20/2018 - 3/11/2018 | 35% |
Astria Therapeutics (ATXS) | 1/20/2018 - 3/11/2018 | 33.99% |
Scpharmaceuticals (SCPH) | 1/20/2018 - 3/11/2018 | 33.81% |
Tandem Diabetes Care (TNDM) | 1/20/2018 - 3/11/2018 | 33.56% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
